# Filing Detail

Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001193125-17-195968
Filing Date
2017-06-06
Accepted
2017-06-06 16:13:33
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-4/A | d177072ds4a.htm | S-4/A | 4279151
2 | EX-23.1 | d177072dex231.htm | EX-23.1 | 1944
3 | EX-23.2 | d177072dex232.htm | EX-23.2 | 1975
4 | GRAPHIC | g177072g01f90.jpg | GRAPHIC | 41154
5 | GRAPHIC | g177072g40g89.jpg | GRAPHIC | 24404
6 | GRAPHIC | g177072g59z18.jpg | GRAPHIC | 34746
7 | GRAPHIC | g177072g96p92.jpg | GRAPHIC | 30329
| Complete submission text file | 0001193125-17-195968.txt |  | 4464361

Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-216961 | Film No.: 17894300
SIC: 2835 In Vitro & In Vivo Diagnostic Substances